<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Suberville, M.</author>
     <author>Zhang, K.</author>
     <author>Woillard, J.B.</author>
     <author>Herafa, I.</author>
     <author>Ducoux, D.</author>
     <author>Nachef, R.</author>
     <author>Teoh, J.</author>
     <author>Zhu, G.</author>
     <author>Chi-Fai Ng</author>
     <author>Laguna, P.</author>
     <author>Jean de la Rosette</author>
    </authors>
   </contributors>
   <titles>
    <title>Oncological and Functional Outcomes of Hemi-Ablation Versus Focal Ablation for Localized Prostate Cancer Using Irreversible Electroporation</title>
   </titles>
   <keywords>
    <keyword>irreversible electroporation</keyword>
    <keyword>side effect</keyword>
    <keyword>patient-reported quality of life</keyword>
    <keyword>prostate&#13;
cancer</keyword>
    <keyword>focal therapy</keyword>
    <keyword>Scopus</keyword>
    <keyword>Web of Science</keyword>
    <keyword>Белый список</keyword>
   </keywords>
   <dates>
    <year>2025</year>
    <pub-dates>
     <date>2026-05-21</date>
    </pub-dates>
   </dates>
   <doi>10.3390/cancers17132084</doi>
   <journal>CANCERS</journal>
   <abstract>For localized prostate cancer, focal therapy uses different sources of energy to treat selected&#13;
areas of the gland, thereby avoiding or limiting damage to surrounding structures and&#13;
aiming to preserve urinary and erectile function. Irreversible electroporation (IRE) is a&#13;
novel tumor ablation technique using a non-thermal energy source, which might have&#13;
potential advantages over other focal therapy modalities and achieve superior functional&#13;
and safety outcomes. The aim of our retrospective study was to assess the oncological&#13;
control, functional outcomes, and quality-of-life results of hemi-IRE ablation versus focal&#13;
IRE ablation therapy for localized prostate cancer patients in a short- to medium-term&#13;
follow-up. We confirmed that both IRE protocols achieved good urinary and erectile&#13;
function outcomes and favorable short-term oncological control and that hemi-IRE ablation&#13;
showed a significantly lower persistence of (clinically significant) prostate cancer compared&#13;
with focal IRE ablation.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/5382</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/5576</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
